|
1
|
Cicenas S, Zaliene A and Atkocius V:
Treatment outcome of locally advanced stage IIIA/B lung cancer.
Medicina (Kaunas). 45:452–459. 2009.(In Lithuanian).
|
|
2
|
Szkorupa M, Klein J, Bohanes T, et al:
Neoadjuvant chemotherapy and surgical treatment in advanced stages
of non-small cell lung cancer. Rozhl Chir. 90:433–439. 2011.(In
Czech).
|
|
3
|
Spásová I: The position of neoadjuvant
chemotherapy in the treatment of non-small-cell lung carcinoma.
Vnitr Lek. 53:715–723. 2007.(In Czech).
|
|
4
|
Lee Y, Kim HY, Lee SH, et al: Clinical
significance of heterogeneity in response to retreatment with
epidermal growth factor receptor tyrosine kinase inhibitors in
patients with lung cancer acquiring secondary resistance to the
drug. Clin Lung Cancer. 15:145–151. 2014. View Article : Google Scholar
|
|
5
|
Goldberg SB, Oxnard GR, Digumarthy S, et
al: Chemotherapy with erlotinib or chemotherapy alone in advanced
non-small cell lung cancer with acquired resistance to EGFR
tyrosine kinase inhibitors. Oncologist. 18:1214–1220. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ju JF, Yu WP, Fu CS and Ma LM: Modern
research and clinical application of β-elemene. Qilu Pharm Affairs.
27:546–548. 2008.
|
|
7
|
Guo HQ, Zhang GN, Wang YJ, et al:
β-elemene, a compound derived from Rhizoma zedoariae, reverses
multidrug resistance mediated by the ABCB1 transporter. Oncol Rep.
31:858–866. 2014.
|
|
8
|
Hao SH, Zhang J and Zhang T: A study of
elemene emulsion treated advanced non small cell lung cancer on
platinum based chemotherapy. Clin Focus. 27:1529–1531. 2012.(In
Chinese).
|
|
9
|
Zhao C, Zhang YC, Sun YY, et al: A study
of elemene injection combined with interventional chemotherapy
treated primary liver cancer. Chin J Diffic Compl Cas. 11:882–883.
2012.(In Chinese).
|
|
10
|
Cheng HD, Yang Z, Zhang MJ, et al:
Clinical observation of elemene combined with paclitaxel/tegafur in
the treatment of advanced esophageal carcinoma. J Anhui Med Pharm.
16:1679–1681. 2012.(In Chinese).
|
|
11
|
Ren W and Du SK: Different effect of
elemene and BCG on preventing the recurrence of postoperative
superficial bladder. J Shaanxi Med. 41:1151–1152. 2012.(In
Chinese).
|
|
12
|
Li QQ, Lee RX, Liang H, Zhong Y and Reed
E: Enhancement of cisplatin-induced apoptosis by β-elemene in
resistant human ovarian cancer cells. Med Oncol. 30:424–444.
2013.
|
|
13
|
Zhang Y, Mu XD, Li EZ, et al: The role of
E3 ubiquitin ligase cbl proteins in reversing multi-drug resistance
of β-elemene human gastric adenocarcinoma cells. Int J Mol Sci.
14:10075–10089. 2013.
|
|
14
|
Miedlich SU, Zalutskaya A, Zhu ED, et al:
Phosphate-induced apoptosis of hypertrophic chondrocytes is
associated with a decrease in mitochondrial membrane potential and
is dependent upon Erk1/2 phosphorylation. J Biol Chem.
285:18270–18275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hong J, Samudio I, Chintharlapalli S, et
al: 1,1-bis (3′-indolyl)-1- (p-substituted phenyl) methanes
decrease mitochondrial membrane potential and induce apoptosis in
endometrial and other cancer cell lines. Mol Carcinog. 47:492–507.
2008.
|
|
16
|
Zuo L and Motherwell MS: The impact of
reactive oxygen species and genetic mitochondrial mutations in
Parkinson’s disease. Gene. 532:18–23. 2013.
|
|
17
|
Circu ML and Aw TY: Glutathione and
modulation of cell apoptosis. Biochim Biophys Acta. 1823:1767–1777.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park HJ, Jeon YK, You DH, et al: Daidzein
causes cytochrome c-mediated apoptosis via the Bcl-2 family in
human hepatic cancer cells. Food Chem Toxicol. 60:542–549. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brentnall M, Rodriguez-Menocal L, De
Guevara RL, et al: Caspase-9, caspase-3 and caspase-7 have distinct
roles during intrinsic apoptosis. BMC Cell Biol. 9:32–40. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gyulkhandanyan AV, Mutlu A, Freedman J, et
al: Markers of platelet apoptosis: methodology and applications. J
Thromb Thrombolysis. 33:397–411. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pucci B, Kasten M and Giordano A: Cell
cycle and apoptosis. Neoplasia. 2:291–299. 2000. View Article : Google Scholar
|
|
22
|
Robertson JD, Orrenius S and Zhivotovsky
B: Review: nuclear events in apoptosis. J Struct Biol. 129:346–358.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tait JF: Imaging of apoptosis. J Nucl Med.
49:1573–1576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Radović N, Cucić S and Altarac S:
Molecular aspects of apoptosis. Acta Med Croatica. 62:249–256.
2008.(In Croatian).
|
|
25
|
Prosperini A, Juan-García A, Font G, et
al: Beauvericin-induced cytotoxicity via ROS production and
mitochondrial damage in Caco-2 cells. Toxicol Lett. 222:204–211.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yan F, Yang WK, Li XY, et al: A
trifunctional enzyme with glutathione S-transferase, glutathione
peroxidase and superoxide dismutase activity. Biochim Biophys Acta.
1780:869–872. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang L, Wang P, Wang H, et al: Fucoidan
derived from Undaria pinnatifida induces apoptosis in human
hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated
mitochondrial pathway. Mar Drugs. 11:1961–1976. 2013.
|
|
28
|
Liu XT, Wang YR and Zhang M:
Mitochondria-mediated apoptosis: a review of recent studies. J
Environ Health. 30:182–184. 2013.
|
|
29
|
Zhao D, Huo LF, Liu H, et al:
Mitochondria, cytochrome c, caspase and cell apoptosis. J Med Pest
Control. 28:1337–1340. 2012.
|
|
30
|
Ng KB, Bustamam A, Sukari MA, et al:
Induction of selective cytotoxicity and apoptosis in human
T4-lymphoblastoid cell line (CEMss) by boesenbergin a isolated from
Boesenbergia rotunda rhizomes involves mitochondrial
pathway, activation of caspase 3 and G2/M phase cell cycle arrest.
BMC Complement Altern Med. 13:41–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ning Y, Riggins RB, Mulla JE, et al:
Interferon α restores breast cancer sensitivity to fulvestrant by
regulating STAT1, IRF1, NF-κB, BCL2 family members, and signaling
to caspase-dependent apoptosis. Mol Cancer Ther. 9:1274–1285.
2010.
|
|
32
|
Liang Y and Sundberg JP: SHARPIN regulates
mitochondria-dependent apoptosis in keratinocytes. J Dermatol Sci.
63:148–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Joshi S, Braithwaite AW, Robinson PJ and
Chircop M: Dynamin inhibitors induce caspase-mediated apoptosis
following cytokinesis failure in human cancer cells and this is
blocked by Bcl-2 overexpression. Mol Cancer. 10:78–103. 2011.
View Article : Google Scholar
|
|
34
|
Favaloro B, Allocati N, Graziano V, et al:
Role of apoptosis in disease. Aging. 4:330–349. 2012.
|
|
35
|
Merhi F, Tang R, Piedfer M, et al:
Hyperforin inhibits Akt1 kinase activity and promotes
caspase-mediated apoptosis involving Bad and Noxa activation in
human myeloid tumor cells. PLoS One. 6:e259632011. View Article : Google Scholar : PubMed/NCBI
|
